Tetramethylpyrazine is used in the treatment of many neurological diseases because of its neuroprotective effect. Here, we demonstrate that administration of tetramethylpyrazine effectively reverses memory deficits induced by scopolamine. Moreover, tetramethylpyrazine preserves postsynaptic protein synthesis and restores cAMP/PKA/CREB pathway signaling deficits. Our study not only explores the actions of tetramethylpyrazine on synapses, but also provides novel evidence for the possible therapeutic use of tetramethylpyrazine in dementia. (C) 2013 Elsevier B.V. All rights reserved.
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430022, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Wu Wei,Yu Xiao,Luo Xiao-Ping,et al.Tetramethylpyrazine protects against scopolamine-induced memory impairments in rats by reversing the cAMP/PKA/CREB pathway[J].BEHAVIOURAL BRAIN RESEARCH.2013,253:212-216.doi:10.1016/j.bbr.2013.07.052.
APA:
Wu, Wei,Yu, Xiao,Luo, Xiao-Ping,Yang, Shu-Hua&Zheng, Dong.(2013).Tetramethylpyrazine protects against scopolamine-induced memory impairments in rats by reversing the cAMP/PKA/CREB pathway.BEHAVIOURAL BRAIN RESEARCH,253,
MLA:
Wu, Wei,et al."Tetramethylpyrazine protects against scopolamine-induced memory impairments in rats by reversing the cAMP/PKA/CREB pathway".BEHAVIOURAL BRAIN RESEARCH 253.(2013):212-216